NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
The summary for the NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required): This Funding Opportunity Announcement (FOA) encourages cooperative agreement applications for implementation of investigator-initiated, high-risk clinical trials and mechanistic studies associated with high-risk clinical trials. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role). Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application.
Federal Grant Title: | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-21-083 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.855 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | January 13th, 2024 |
Original Application Deadline: | January 13th, 2024 |
Posted Date: | January 14th, 2021 |
Creation Date: | January 14th, 2021 |
Archive Date: | February 18th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | January 21st, 2022 |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-21-083.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
- • Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Anti...
- • Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...